Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week
Here are Thursday's biggest analyst calls: Nvidia, Costco, Apple, Snowflake, Meta, Nike, Disney, Airbnb & more
Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.
Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.
5 Stocks that Analysts Love in March 2024
Truist Financial Reaffirms Their Hold Rating on AnaptysBio (ANAB)
Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts
What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock
What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock
Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade
Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD)
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), AnaptysBio (ANAB) and iTeos Therapeutics (ITOS)
J.P. Morgan Reaffirms Their Hold Rating on AnaptysBio (ANAB)
Strong Buy Rating for AnaptysBio Based on Promising Pipeline and Financial Health
AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates
AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.